Semantic Scholar uses AI to extract papers important to this topic.
Drug selection of rapid acting fentanyl formulations in the treatment of breakthrough pain in patients with cancer is performed… Expand PurposeInstanyl® (intranasal fentanyl spray) is a novel treatment for breakthrough pain (BTP) in cancer patients. It has shown a… Expand Objective: Breakthrough cancer pain (BTcP) affects 19-95% of cancer patients (dependent on the definition and methods used and… Expand Opioids are considered important analgesics in the treatment armamentarium for moderate-to-severe background cancer pain. The… Expand Objective: Determine, with a pharmacoeconomic evaluation, the effectiveness and efficiency of fentanyl pectin intranasal spray… Expand The nasal cavity has for more than three decades been widely explored as a potential alternative route to oral or parenteral… Expand 1 Polyclinique de l’Ormeau, Tarbes. 2 Hôpital André-Mignot, Le Chesnay. 3 Institut Paoli-Calmette, Marseille. 4 CH de Bayeux. 5… Expand Fentanyl, a potent opioid analgesic, is rapidly and efficiently absorbed from the nasal cavity, giving significant potential for… Expand Oral normal-release morphine has long been considered the gold-standard treatment for cancer breakthrough pain. However, its… Expand Instanyl is an intranasal formulation of fentanyl licensed for breakthrough pain management in chronic cancer pain. In our New… Expand